| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/22/1999 | WO1999019339A1 53 human secreted proteins |
| 04/22/1999 | WO1999018995A1 Immunogenic peptides from the hpv e7 protein |
| 04/22/1999 | WO1999018976A1 Therapeutic methods comprising use of a neuregulin |
| 04/22/1999 | WO1999018933A2 Methods for encapsulating nucleic acids in lipid bilayers |
| 04/22/1999 | WO1999018799A1 Treatment of neoplasms with viruses |
| 04/22/1999 | WO1999018792A1 Gene delivery compositions and methods |
| 04/22/1999 | WO1999013886B1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications |
| 04/22/1999 | WO1999006561A3 Chemokine receptor ccr8 dna and uses thereof |
| 04/22/1999 | WO1999004806A9 Methods and compositions for inhibiting angiogenesis |
| 04/22/1999 | WO1999004011A3 Hiv-1 group o antigens and uses thereof |
| 04/22/1999 | WO1998053068A9 Smad7 and uses thereof |
| 04/22/1999 | WO1998045328A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 04/22/1999 | WO1998044788A9 Animal model for evaluation of vaccines |
| 04/22/1999 | WO1998044143A9 Polymer-modified viruses |
| 04/22/1999 | WO1998036779A3 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| 04/22/1999 | WO1997038729A8 In vivo gene transfer methods for wound healing |
| 04/22/1999 | CA2792406A1 Methods for encapsulating nucleic acids in lipid bilayers |
| 04/22/1999 | CA2696653A1 Mammalian genes involved in viral infection and tumor suppression |
| 04/22/1999 | CA2315244A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/22/1999 | CA2308118A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 04/22/1999 | CA2306453A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 04/22/1999 | CA2306451A1 Methods and compositions for detecting hepatitis e virus |
| 04/22/1999 | CA2306448A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 04/22/1999 | CA2306444A1 Inhibition of human immunodeficiency virus (hiv-1) replication |
| 04/22/1999 | CA2306443A1 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
| 04/22/1999 | CA2306440A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 04/22/1999 | CA2306228A1 Therapeutic methods comprising use of a neuregulin |
| 04/22/1999 | CA2305690A1 53 human secreted proteins |
| 04/22/1999 | CA2305643A1 Murine model for human carcinoma |
| 04/22/1999 | CA2248762A1 Antisense oligodeoxynucleotides regulating expression of tnf-.alpha. |
| 04/21/1999 | EP0909820A2 Histidine kinase from Staphylococcus pneumoniae |
| 04/21/1999 | EP0909325A2 Pi 3-kinase fusion mutants and uses thereof |
| 04/21/1999 | EP0909319A2 Growth arrest gene compositions and methods |
| 04/21/1999 | EP0909317A1 Composition and methods for modulating the length of telomeres |
| 04/21/1999 | EP0909272A1 Helicobacter pylori adhesin binding group antigen |
| 04/21/1999 | EP0909181A1 Novel compounds |
| 04/21/1999 | EP0909180A1 Novel compounds |
| 04/21/1999 | CN1214735A IgA nephropathy-associated gene |
| 04/21/1999 | CA2248169A1 Dnag |
| 04/20/1999 | US5895759 Vector for gene transfer in liver cells |
| 04/15/1999 | WO1999018226A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/15/1999 | WO1999018222A1 Use of beta recombinase in eukaryotic cells, especially for transgenic work |
| 04/15/1999 | WO1999018221A1 Method for introducing and expressing rna in animal cells |
| 04/15/1999 | WO1999018214A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 04/15/1999 | WO1999018208A1 101 human secreted proteins |
| 04/15/1999 | WO1999018207A1 Human hox c10 and polynucleotides encoding |
| 04/15/1999 | WO1999018197A2 Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (apeced) |
| 04/15/1999 | WO1999018195A2 Methods and compositions for inducing tumor-specific cytotoxicity |
| 04/15/1999 | WO1999018193A1 Jnk3 modulators and methods of use |
| 04/15/1999 | WO1999018187A1 NOVEL clpL |
| 04/15/1999 | WO1999018128A1 Fibroblast growth factor with hepatocyte proliferation activity |
| 04/15/1999 | WO1999018117A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus |
| 04/15/1999 | WO1999017807A1 Use of a vasoactive compound in the enhancement of gene delivery |
| 04/15/1999 | WO1999017800A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | WO1999017798A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/15/1999 | WO1999017797A1 Use of growth differenciation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | WO1999017795A1 RIBOSOME RECYCLING FACTOR (FRR) OF $i(STAPHYLOCOCCUS AUREUS) |
| 04/15/1999 | WO1999017741A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | WO1999017610A1 Protein delivery by secretory gland expression |
| 04/15/1999 | WO1999005300A3 Ghrh expression system and methods of use |
| 04/15/1999 | WO1999005170A8 NOVEL ESTROGEN β RECEPTOR AND ISOFORMS |
| 04/15/1999 | WO1999002647A3 Cloning vectors for producing adenoviral minimal viruses |
| 04/15/1999 | WO1999002171A9 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 04/15/1999 | WO1999000422A9 Novel family of pheromone receptors |
| 04/15/1999 | WO1998059050A9 Cloning of a gene mutation for parkinson's disease |
| 04/15/1999 | WO1998045322A3 Diagnosis method and reagents |
| 04/15/1999 | DE19821060A1 Ko-stimulierendes Polypeptid von T-Zellen, monoklonale Antikörper sowie die Herstellung und deren Verwendung Co-stimulatory polypeptide of T-cells, monoclonal antibodies and the production and use thereof |
| 04/15/1999 | CA2308123A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | CA2306452A1 Use of growth differentiation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | CA2305815A1 Use of beta recombinase in eukaryotic cells, especially for transgenic work |
| 04/15/1999 | CA2305785A1 Method for introducing and expressing rna in animal cells |
| 04/15/1999 | CA2305709A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | CA2305685A1 101 human secreted proteins |
| 04/15/1999 | CA2305682A1 Fibroblast growth factor with hepatocyte proliferation activity |
| 04/15/1999 | CA2304803A1 Protein delivery by secretory gland expression |
| 04/15/1999 | CA2304354A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/15/1999 | CA2304350A1 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/14/1999 | EP0908519A1 Novel glucosaminidase from Staphylococcus aureus |
| 04/14/1999 | EP0908518A2 MurE gene encoding uridine-diphosphate-N-acetylmuramoyl-L-alanyl-D-glutamate:L-lysine ligase of Streptococcus pneumoniae |
| 04/14/1999 | EP0908517A2 Viral vaccines |
| 04/14/1999 | EP0908516A1 ABC transporter |
| 04/14/1999 | EP0908514A1 LicD1 polyperides from Streptococcus pneumoniae |
| 04/14/1999 | EP0907746A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/14/1999 | EP0907738A1 Novel compounds |
| 04/14/1999 | EP0907735A1 Modulators of tissue regeneration |
| 04/14/1999 | EP0907730A1 Haemopoietin receptor and genetic sequences encoding same |
| 04/14/1999 | EP0907729A1 HUMAN P2x4 RECEPTOR SPLICE-VARIANTS |
| 04/14/1999 | EP0907720A1 Combined radiotherapy and immunotherapy to treat cancer |
| 04/14/1999 | EP0907719A1 Human cytokine polypeptide |
| 04/14/1999 | EP0907377A1 Novel compounds |
| 04/14/1999 | EP0907376A1 Novel compounds |
| 04/14/1999 | EP0907375A1 Novel compounds |
| 04/14/1999 | EP0907370A1 Hla-a2.1 binding peptides and their uses |
| 04/14/1999 | EP0734436B1 Inhibition of dna methyltransferase |
| 04/14/1999 | CN1214050A Human tumor necrosis factor delta and epsilon |
| 04/10/1999 | CA2246632A1 Novel mure |
| 04/09/1999 | CA2246635A1 Novel glucosaminidase |
| 04/08/1999 | WO1999016892A1 Bovine herpesvirus 2 (bhv-2) based vector and its uses |
| 04/08/1999 | WO1999016889A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment |
| 04/08/1999 | WO1999016888A2 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |